Related Experiment Video
Updated: Feb 15, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
A Pediatric Patient with Idiopathic Short Stature Who Developed Obstructive Sleep Apnea after Starting Growth Hormone
Morkous Ss1,2,3
1Department of Pediatrics, Pediatric Neurology Division, Lehigh Valley Children's Hospital, Allentown, PA, USA.
Insights
Growth hormone (GH) therapy may worsen obstructive sleep apnea (OSA) in children. This case study suggests careful sleep monitoring during GH treatment for idiopathic short stature is needed.
Area of Science:
- Pediatric Endocrinology
- Sleep Medicine
- Genetics
Background:
- Growth hormone (GH) therapy is suspected to induce obstructive sleep apnea (OSA).
- Concerns exist regarding GH worsening sleep apnea, particularly in Prader-Willi syndrome (PWS).
- Routine polysomnography (PSG) is recommended for PWS patients before GH, but not established for other pediatric groups.
Purpose of the Study:
- To highlight the potential link between GH therapy and the development of OSA in pediatric patients.
- To emphasize the need for vigilance regarding sleep-related side effects of GH treatment.
- To advocate for further research into PSG guidelines for GH-eligible children.
Main Methods:
- Case report of a 15-year-old male with headaches and short stature.
- Initial sleep study showed mild snoring; a follow-up study after GH therapy revealed significantly worsened obstructive sleep apnea.
- Surgical intervention (tonsillectomy and adenoidectomy) led to symptom resolution.
Main Results:
- A 15-year-old patient on GH therapy experienced a dramatic increase in his obstructive apnea-hypopnea index.
- Symptoms of worsening sleep apnea resolved post-tonsillectomy and adenoidectomy.
- The case underscores a potential complication of GH therapy.
Conclusions:
- GH therapy may necessitate careful consideration of sleep apnea risks.
- Further research is needed to establish definitive guidelines for PSG before and during GH therapy in children with idiopathic short stature and initially normal sleep studies.
- Caution is advised for all patients eligible for GH therapy regarding potential sleep disturbances.
Background:
Growth hormone (GH) therapy has long been suspected to induce obstructive sleep apnea (OSA) in children and adults. Moreover, reports about GH-associated sudden death in children with Prader-Willi syndrome (PWS) have prompted concerns about GH worsening sleep apnea. Previous studies have supported routine polysomnography for children with PWS prior to starting GH treatments, regardless of clinical history. However, there are no established guidelines recommending routine polysomnography (PSG) prior to the commencement of GH therapy in other pediatric patients.
Case Description:
We report a case of a 15-year-old young man with intractable headaches, referred to the sleep clinic to rule out any sleep-related variables. After an initial non-significant (mild snoring) sleep study, the patient returned with worsening snoring about one year after starting GH therapy for concerns of short stature.
Results:
A second polysomnogram revealed that his obstructive apnea-hypopnea index had risen dramatically from baseline. His symptoms resolved after tonsillectomy and adenoidectomy.
Conclusion:
This interesting case highlights the need for caution with any patient eligible for GH therapy. We recommend additional research to look in the development of definitive guidelines regarding the indications for polysomnography for patients with idiopathic short stature and non-significant initial sleep history-particularly before and during the administration of GH therapy.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Continuous Renal Replacement Therapy
Types of Hormones
Pharmacokinetics in Pediatric Patients: Drug Excretion
Plant Hormones
Pharmacokinetics in Pediatric Patients: Drug Distribution

